Stanford Cancer Institute (SCI) — Stanford, California

Stanford Cancer Institute (SCI) is a clinical research site located in Stanford, California, United States 94305.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Stanford Cancer Institute (SCI) has participated in 5 clinical trials with 1 currently active.

Therapeutic areas: AL Amyloidosis, Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer, Primary Systemic (AL) Amyloidosis.

Sponsors: Prothena Biosciences Ltd., Hoffmann-La Roche, Takeda.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford Cancer Institute (SCI)?

Stanford Cancer Institute (SCI) has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford Cancer Institute (SCI) conducted?

Stanford Cancer Institute (SCI) has 5 clinical trials on record, with 1 currently active. Their work covers AL Amyloidosis, Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer, Primary Systemic (AL) Amyloidosis.

Is Stanford Cancer Institute (SCI) accredited by Crixeo Health?

Stanford Cancer Institute (SCI) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford Cancer Institute (SCI)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.